Skip to main content
construction release_alert
Profile editing is temporarily unavailable from June 11-24, 2026 while manual profile data entry transitions to Elements. Learn More.
cancel

Alaattin Erkanli

Associate Professor of Biostatistics & Bioinformatics
Biostatistics & Bioinformatics, Division of Biostatistics
Hock Plaza Box 2721, Durham, NC 27710
Duke University Medical Center 2424, Erwin Road Suite 110 Hock Plaza Box 2721, Durham, NC 27710

Overview


Areas of research interests include Bayesian hierarchical models for longitudinal data, Bayesian optimal designs, finite mixtures and Mixtures of Dirichlet Processes, Markov transition models, nonparametrics smoothing and density estimation, survival analysis for recurrent-event data, biomarker selection and detecting early ovarian cancer.

Current Appointments & Affiliations


Associate Professor of Biostatistics & Bioinformatics · 2022 - Present Biostatistics & Bioinformatics, Division of Biostatistics, Biostatistics & Bioinformatics

Recent Publications


The association between postpartum aspirin use and NT-proBNP levels as a marker for maternal cardiac health: a randomized controlled trial.

Journal Article Am J Obstet Gynecol · May 2026 BACKGROUND: During pregnancy, administration of low-dose aspirin 81 mg (LDA) has been demonstrated to decrease the incidence of preeclampsia in at-risk individuals. However, the role of continuation of LDA in the postpartum period and its association with ... Full text Link to item Cite

Are two really better than one? A retrospective study comparing monotherapy versus combination therapy for Stenotrophomonas maltophilia infections.

Journal Article Microbiol Spectr · April 7, 2026 Management of Stenotrophomonas maltophilia infections is challenging. The Infectious Diseases Society of America recommends up-front combination therapy, though this may increase toxicity without clear benefit. We compared combination therapy (CT) versus m ... Full text Link to item Cite
View All Publications

Recent Grants


Geriatric oncology assessment to link with support for older women taking adjuvant aromatase inhibitor therapy

ResearchCo Investigator · Awarded by National Institutes of Health · 2026 - 2031

PFAS exposure is detrimental to placental function and fetal development by disrupting mitochondrial function and metabolism

ResearchClinical Investigator · Awarded by National Institutes of Health · 2025 - 2029

Perinatal Per- and Polyfluoroalkyl Substances (PFAS) exposure and Immunotoxicity

ResearchStatistician · Awarded by National Institute of Environmental Health Sciences · 2023 - 2028

View All Grants

Education


Carnegie Mellon University · 1991 Ph.D.